Physician profile
Saquib Samee
NPI 1548376080
$7,299.04
in general payments reported to CMS, 2019-2025
31 companies · $2,641 in 2025
The $2,641 reported for 2025 was more than what 87% of Cardiovascular Disease providers received nationally (typical 2025 total: $433).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2019: $928 · 2020: $588 · 2021: $721 · 2022: $421 · 2023: $966 · 2024: $1,035 · 2025: $2,641.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Food and Beverage: $2,837 · Travel and Lodging: $1,804.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Food and Beverage | $2,837.03 |
| Travel and Lodging | $1,804.35 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Philips North America LLC | $2,459.23 | 2020-2025 | IV Other, Igt Devices Undivided, (Br5) Peripheral Ivus |
| Medtronic, INC. | $788.35 | 2021-2024 | Closurefast, Venaseal, Turbohawk |
| Bard Peripheral Vascular, INC. | $763.64 | 2024-2025 | Venclose Maven Catheter, Venovo |
| Tactile Systems Technology INC | $448.32 | 2019-2022 | |
| Abbott Laboratories | $422.05 | 2019-2025 | Mitraclip |
| Boston Scientific Corporation | $414.02 | 2019-2024 | Varithena Administration Pack |
| Cardiva Medical, INC. | $252.32 | 2019-2022 | |
| Biocompatibles, INC. | $190.02 | 2019 | |
| Medtronic Vascular, INC. | $176.29 | 2019-2020 | |
| Janssen Pharmaceuticals, INC | $175.31 | 2019-2023 | Xarelto |
| Pharming Healthcare, INC. | $124.74 | 2023 | Joenja |
| Abiomed | $124.65 | 2019 | |
| Blueprint Medicines Corporation | $121.59 | 2024 | Ayvakit |
| Novartis Pharmaceuticals Corporation | $101.94 | 2020 | |
| Astrazeneca Pharmaceuticals Lp | $93.85 | 2019 |
Show all 31 companies
| Company | General payments | Years | Top products |
|---|---|---|---|
| Pfizer INC. | $90.97 | 2019 | |
| Becton, Dickinson and Company | $85.18 | 2025 | Rotarexs 6 F X 135 Cm |
| Cook Medical LLC | $61.50 | 2022 | |
| Venclose INC. | $54.02 | 2020 | |
| Bardy Diagnostics, INC. | $52.29 | 2020-2022 | |
| Angiodynamics, INC. | $44.07 | 2021 | |
| Cordis US Corp. | $37.14 | 2022-2024 | Mynxgrip |
| Amgen INC. | $35.37 | 2023 | Repatha, Otezla |
| E.R. Squibb & Sons, L.L.C. | $32.63 | 2025 | Camzyos |
| Edwards Lifesciences Corporation | $31.20 | 2020 | |
| Convatec INC. | $28.30 | 2024 | |
| Veryan Medical Incorporated | $22.59 | 2021 | |
| Nuwellis, INC. | $21.35 | 2019 | |
| Viatris Specialty LLC | $17.37 | 2025 | Yupelri |
| Fortis Surgical, LLC | $15.76 | 2024 | |
| Merit Medical Systems INC | $12.98 | 2021 |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Saquib Samee listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.